Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling

Similar documents
Managing Insomnia Disorder A Review of the Research for Adults

Learning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD

SLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla

Ambien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that

TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE

Insomnia: Updates in Medical Management. Michael Newnam M.D.

CPT David Shaha, MC US Army

Insomnia Agents (Sherwood Employer Group)

Insomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4

Insomnia treatment in primary care

Insomnia. Arturo Meade MD

Dr Alex Bartle. Sleep Well Clinic

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES. SEDATIVE HYPNOTIC AGENTS Generic Brand HICL GCN Exception/Other ZOLPIDEM

Insomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)

DRUGS THAT ACT IN THE CNS

Treating sleep disorders

Insomnia Disorder A Journey to the Land of No Nod

You May Be at Risk. You are currently taking a sedative-hypnotic drug. Please Bring This Information With You To Your Next Medical Appointment

How to Manage Insomnia with and without medications

Insomnia Treatment in Brief

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA

Insomnia treatment. Sleep hygiene education sleep hygiene teaches good sleeping habits. This includes:

Revolutionizing Cost Management... One Person at a Time.

WHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?)

Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles

Beyond Sleep Hygiene: Behavioral Approaches to Insomnia

YOU REALLY NEED TO SLEEP: Several methods to improve your sleep

What is sleep? o Sleep is a body s rest cycle.

continuing education for pharmacists

Insomnia. Dr Terri Henderson MBChB FCPsych

AGING CHANGES IN SLEEP

Sleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER

Insomnia Pearls in the Geriatric Population

See Important Reminder at the end of this policy for important regulatory and legal information.

You May Be at Risk. You are taking one of the following sedative-hypnotic medications: Diazepam (Valium ) Estazolam. Flurazepam.

Can you take ambien with doxepin

Sleep and Parkinson's Disease

The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3

3/24/2016 DISCLOSURE STATEMENT PHARMACIST OBJECTIVES OVERVIEW TECHNICIAN OBJECTIVES PREVALENCE OF INSOMNIA THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA

SEDATIVE-HYPNOTIC AGENTS

Question #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia

You May Be at Risk. You are taking one of the following sedative-hypnotic medications:

Sleep and Traumatic Brain Injury (TBI)

Diagnosis and Treatment of Chronic Insomnia: A Review. underdiagnosed, and undertreated

Sleep in Children and Teens: Medical Aspects

Comparison of Insomnia Treatments

See Important Reminder at the end of this policy for important regulatory and legal information.

Sleep History Questionnaire

ACTIVITY DESCRIPTION Target Audience Learning Objectives

Sedative Hypnotics. Description

Ramelteon to ambien The Borg System is 100 % Retrievable & Reusable Ramelteon to ambien

Treating Insomnia in Primary Care. Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team

Chronic Insomnia: DSM - V. Insomnia DSM - V. Patient Symptoms. Insomnia: Assessment and Overview of Management. Insomnia Management in the Digital Age


Objectives. Disclosure. APNA 26th Annual Conference Session 2017: November 8, Kurtz 1. The speaker has no conflicts of interest to disclose

DSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time)

Sedative Hypnotics. Description

Sleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know

Temazepam 30 mg sleeping pills

See Important Reminder at the end of this policy for important regulatory and legal information.

A Pharmacist s Guide to Intermezzo

Definitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months

OBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep

Seminar. Chronic insomnia

48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014

VI.2 Elements for a Public Summary

CBT for Insomnia: Past, Present, and Future Directions

Cognitive Behavioral Therapy for Insomnia. Melanie K. Leggett, PhD, CBSM Duke University Medical Center

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Sleep Hygiene. William M. DeMayo, M.D. John P. Murtha Neuroscience and Pain Institute Conemaugh Health System Johnstown, PA

Does Zolpidem cause Low Blood Pressure? Last Update and then sedatives like zolpidem / ambien lower bp and i was thinking that this could be

Drug Class Review on Newer Drugs for Insomnia

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before

Many people with physical

Sleep Disorders. Solving Clinical Challenges in. David N. Neubauer, MD

Anxiolytic and Hypnotic drugs

RETT SYNDROME AND SLEEP

The most common problem in young people with insomnia is difficulty falling asleep (sleep-onset insomnia). An insomniac may also experience:

Article printed from

ADULT PRIMARY INSOMNIA

Insomnia: Its Causes & Solutions

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children

Sleep Healthy, Live Healthy By: Gary E. Foresman, MD

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Drugs used to relieve behavioural and psychological symptoms in dementia

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

INSOMNIAS. Stephan Eisenschenk, MD Department of Neurology

Psychotropic Medication Use in Dementia

Drug Review Rozerem (ramelteon)

Wide Awake: Managing Insomnia

Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers

Sleep Disorders. Guidance for Primary Care. National Advisory Group for Respiratory Managed Clinical Networks

TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE

Insomnia: habits, help, and hazards

INDEX. Group psychotherapy, described, 97 Group stimulus control, 29-47; see also Stimulus control (group setting)

일차진료에서불면증치료 김종우. Primary Insomnia : DSM-IV criteria 경희대학교의과대학정신과학교실 MEMO. Diagnostic Criteria for Insomnia (ICSD-2) 개원의와함께하는임상강좌

Chapter 7. Depressants and Inhalants. Depressants & Inhalants. History: Before Barbiturates 10/1/2012

Transcription:

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to: 1. Describe the impact of insomnia on overall health, well-being, and productivity 2. Assist in the assessment of insomnia for patients of all ages and for patients with comorbid conditions 3. Provide education to patients and families on how sleep hygiene and cognitive behavioral interventions can improve sleep 4. Compare the advantages and disadvantages of available pharmacologic treatments for insomnia 5. Provide counseling to patients and families regarding the safe and effective use of prescription and non-prescription sleep aids Post-Test/Rationale 1. Individuals with persistent insomnia who sleep fewer than 6 hours nightly are at increased risk for what chronic health condition? A. Asthma B. Hypothyroidism C. Obesity*** D. Anemia Obesity is a well-established consequence of persistent insomnia; the other medical conditions listed are not consequences of persistent insomnia. 2. In order to keep track of factors that impact quality and quantity of sleep, the National Sleep Foundation s sleep diary asks a person to record which of the following in the morning upon awakening? A. The number of midnight awakenings*** B. The amount of exercise the day before C. The amount of alcohol consumed the night before D. A list of medications ingested the previous morning Correct answer: A The National Sleep Foundation s sleep diary prompts individuals to record the number of middle-of-the-night awakenings each morning. The amount of exercise, alcohol ingested, and medications should be recorded at the end of the day. 3. According to the Centers for Disease Control and Prevention, drowsy driving is a factor in % of traffic accidents.

A. 5% B. 10% C. 20%*** D. 30% Drowsy driving is a factor in 20% of traffic accidents. 4. According to the Agency for Healthcare Research and Quality s executive summary on managing insomnia, a 35-year-old with trouble falling asleep and staying asleep is most likely to benefit from which of the following sleep aids? A. Eszopiclone*** B. Trazodone C. Diphenhydramine D. Temazepam Correct answer: A According to available research, the Agency for Healthcare Research and Quality lists eszopiclone as the most effective agent for trouble falling asleep and staying asleep. 5. A 60-year-old man with major depression and generalized anxiety disorder has been taking sertraline 100 mg daily for 2 weeks with partial improvement in depressive symptoms but ongoing difficulty falling asleep. He has no history of substance abuse. Which of the following agents is effective for insomnia in patients with depression and anxiety disorders and could help this patient? A. Ramelteon 8 mg B. Suvorexant 10 mg C. Zolpidem 5 mg*** D. Doxepin 6 mg Zolpidem would be the best choice for this patient. None of the other agents have been systematically studied and found to be safe and effective for managing insomnia in patients with comorbid depression and anxiety. 6. Which of the following statements is most important to include when counseling a 45- year-old woman receiving a prescription for zolpidem 10 mg for insomnia? A. Take it with a snack in order to increase absorption and effectiveness B. Do not take it longer than 7 consecutive days to prevent rebound insomnia C. Rarely, this medicine can cause sleep paralysis, nightmares, and hallucinations D. Ask your prescriber about only taking 5 mg if you experience next-day impairment***

Correct answer: D Zolpidem is best taken on an empty stomach for fast onset. It is not associated with rebound insomnia. Choice C is an accurate counseling point, but it is not as important as preventing next-day impairment by taking a lower dose. 7. Which of the following techniques involves counseling a patient to get out of bed and go into another room when unable to sleep instead of tossing and turning in bed? A. Stimulus control B. Sleep restriction*** C. Cognitive therapy D. Sleep hygiene Correct answer: B The behavioral technique of sleep restriction involves limiting time in bed to sleeping; patients are encouraged to get out of bed and do another activity before getting back into bed. 8. An obese person with trouble falling asleep and staying asleep may require a lower than usual dose of which hypnotic? A. Zaleplon B. Triazolam C. Zolpidem CR D. Suvorexant*** Correct answer: D Suvorexant blood levels are higher in obese patients, which means that obese patients may need a lower dose than non-obese patients to achieve the same outcomes. This is not the case for the other hypnotics listed. 9. On average, cognitive behavioral therapy for insomnia takes how many weeks to implement? A. 1 to 2 B. 2 to 4 C. 3 to 6*** D. 6 to 8 It can take 3 to 6 weeks for cognitive behavioral strategies to improve insomnia, according to the review paper by Morin and Benca that was published in 2012. 10. Next-day irritability and dysphoria are possible side effects of which agent commonly prescribed for difficulty falling asleep and staying asleep?

A. Zolpidem B. Trazodone*** C. Temazepam D. Amitriptyline Correct answer: B Trazodone has been associated with irritability and dysphoria in some patients receiving trazodone for insomnia, particularly if they also take a cytochrome P450 2D6- inhibiting antidepressant such as fluoxetine or paroxetine. This side effect is thought to be caused by the active metabolite, meta-chlorophenylpiperzine.

Post-test Answer Key: 1. C 2. A 3. C 4. A 5. C 6. D 7. B 8. D 9. C 10. B